Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy
Susanna Esposito(University of Parma), Nicola Principi(University of Milan), Gayatri Amirthalingam(UK Health Security Agency), Juan Pablo Torres(Universidad de Santiago de Chile), Natasha Halasa, Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Matteo Bassetti(Ospedale Policlinico San Martino), Francesco Giuseppe De Rosa(University of Turin), Antonio Vena(Ospedale Policlinico San Martino), Albert Osterhaus(University of Veterinary Medicine Hannover, Foundation), Tina Q. Tan, Francesco Blasi(University of Milan)
Cited by 28
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
|Gastroenterology|2020|1.7k
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k